Danaher to buy Nobel Biocare Holding for $2.2 billion including debt

Sept 15 (Reuters) - U.S. healthcare conglomerate Danaher Corp said it will buy Nobel Biocare Holding in an all-cash deal valued at about $2.2 billion, including debt, to widen its market presence in the global dental industry.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.